Mark Nelson

Company: Wake Forest Baptist Health

Job title: Assistant Professor - Ophthalmology

Seminars:

Panel Discussion: State of Play of Retinal Vascular Drug Development 9:00 am

What are the unique challenges of developing safe and efficacious drugs for Wet AMD vs DR vs DME? How are these different from the challenges when developing therapeutics for Dry AMD and GA? What do the current clinical pipelines look like for Wet AMD vs DR vs DME vs RVO? What does the future of…Read more

day: Conference Day 1

Evaluating Anti-VEGF Non-Responders in Large Portions of Patient Populations & Treating Underlying Diseases to Prevent Disease Progression into Wet AMD, DME, DR & RVO Patients 2:05 pm

For the past 20 years, the VEGF pathway has been the most exploited and researched therapeutic target for retinal vascular diseases. For majority of the patient population, targeting this pathway with anti-VEGF antibodies has been successful, however, a large portion of patients remain untreated due to anti-VEGF resistance. Join your peers as they discuss: Uncovering…Read more

day: Pre-Conference Workshop